After activating the EGFR/Ras pathway in tumor cells, JX-594 as an oncolytic poxvirus can enter the tumor cells and proceed to undergo replication, transgene expression, and amplification, eventually inducing cancer cell lysis and triggering antitumor immunity elevation. This evidence concerns the gene EGFR and neoplasm.